BIOGEN INC. Repayments of Debt
BIOGEN INC. (BIIB) reported Repayments of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2023-02-15
- BIOGEN INC. repayments of debt for the quarter ending 2021-12-31 was -$170.00M, a 111.33% decline year-over-year.
- BIOGEN INC. repayments of debt for the quarter ending 2021-09-30 was $0.00.
- BIOGEN INC. repayments of debt for the quarter ending 2021-06-30 was $700.00K.
- BIOGEN INC. repayments of debt for the quarter ending 2021-03-31 was $169.30M.
- BIOGEN INC. repayments of debt for fiscal 2022 was $0.00.
- BIOGEN INC. repayments of debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BIOGEN INC. repayments of debt for fiscal 2020 was $1.50B.
- BIOGEN INC. repayments of debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month | Repayments of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-15 | ||||
| 2021-12-31 | -$170.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$170.00M derived: sum of 2 quarters · filed 2023-02-15 | -$169.30M derived: sum of 3 quarters · filed 2023-02-15 | $0.00 10-K · filed 2023-02-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $700.00K derived: sum of 2 quarters · filed 2021-10-20 | $170.00M 10-Q · filed 2021-10-20 | $1.67B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $170.00M 10-Q · filed 2021-07-22 | $1.67B derived: sum of 3 quarters · filed 2023-02-15 | $1.67B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-03-31 | $169.30M 10-Q · filed 2021-04-22 | $1.67B derived: sum of 2 quarters · filed 2023-02-15 | $1.67B derived: sum of 3 quarters · filed 2023-02-15 | $1.67B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2020-12-31 | $1.50B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $1.50B derived: sum of 2 quarters · filed 2023-02-15 | $1.50B derived: sum of 3 quarters · filed 2023-02-15 | $1.50B 10-K · filed 2023-02-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $0.00 derived: sum of 2 quarters · filed 2021-10-20 | $0.00 10-Q · filed 2021-10-20 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $0.00 10-Q · filed 2021-07-22 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-22 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-03 | ||||
| 2018-12-31 | $3.20M 10-K · filed 2021-02-03 | ||||
| 2017-12-31 | $560.90M 10-K · filed 2020-02-06 | ||||
| 2016-12-31 | $2.70M 10-K · filed 2019-02-06 | ||||
| 2015-12-31 | $2.10M 10-K · filed 2018-02-01 | ||||
| 2014-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $2.70M derived: sum of 2 quarters · filed 2017-02-02 | $2.70M derived: sum of 3 quarters · filed 2017-02-02 | $2.70M 10-K · filed 2017-02-02 | $2.67M 10-K · filed 2015-02-04 |
| 2014-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $2.67M derived: sum of 2 quarters · filed 2014-10-22 | $2.67M 10-Q · filed 2014-10-22 | $2.73M derived: sum of 4 quarters · filed 2016-02-03 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $0.00 10-Q · filed 2014-07-23 | $60.00K derived: sum of 3 quarters · filed 2016-02-03 | $60.00K derived: sum of 4 quarters · filed 2016-02-03 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-04-23 | $60.00K derived: sum of 2 quarters · filed 2016-02-03 | $60.00K derived: sum of 3 quarters · filed 2016-02-03 | $2.40M derived: sum of 4 quarters · filed 2016-02-03 | |
| 2013-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $60.00K derived: sum of 2 quarters · filed 2016-02-03 | $2.40M derived: sum of 3 quarters · filed 2016-02-03 | $452.40M 10-K · filed 2016-02-03 | $452.34M 10-K · filed 2014-02-06 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $2.34M derived: sum of 2 quarters · filed 2014-10-22 | $452.34M 10-Q · filed 2014-10-22 | $454.77M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2013-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $452.34M 10-Q · filed 2014-07-23 | $454.77M derived: sum of 3 quarters · filed 2015-02-04 | $454.77M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2013-03-31 | $450.00M 10-Q · filed 2014-04-23 | $452.43M derived: sum of 2 quarters · filed 2015-02-04 | $452.43M derived: sum of 3 quarters · filed 2015-02-04 | $452.43M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2012-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $2.43M derived: sum of 2 quarters · filed 2015-02-04 | $2.43M derived: sum of 3 quarters · filed 2015-02-04 | $2.43M 10-K · filed 2015-02-04 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 2 quarters · filed 2013-10-28 | $0.00 10-Q · filed 2013-10-28 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $0.00 10-Q · filed 2013-07-25 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-04-25 | ||||
| 2011-12-31 | $11.46M 10-K · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |